Evidence map›Paper›PMID 39814886›Full record

ArticleNature2025

Prolonged persistence of mutagenic DNA lesions in somatic cells.

Michael Spencer Chapman, Emily Mitchell, Kenichi Yoshida, Nicholas Williams, Margarete A Fabre, Anna Maria Ranzoni, Philip S Robinson, Lori D Kregar, Matthias Wilk, Steffen Boettcher and 16 more

Abstract read
In one paragraph

Article in Nature, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Topographical archetypes of somatic mutagenesis in cancer.bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Michael Spencer ChapmanWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-5320-8193
Emily MitchellWellcome Sanger Institute, Hinxton, UK.
Kenichi YoshidaWellcome Sanger Institute, Hinxton, UK.
Nicholas WilliamsWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0003-3989-9167
Margarete A FabreWellcome Sanger Institute, Hinxton, UK.
Anna Maria RanzoniWellcome Sanger Institute, Hinxton, UK.
Philip S RobinsonWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-6237-7159
Lori D KregarWellcome Sanger Institute, Hinxton, UK.
Matthias WilkDepartment of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0001-5429-7143
Steffen BoettcherDepartment of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0001-9937-0957
Krishnaa MahbubaniDepartment of Surgery, University of Cambridge, Cambridge, UK.ORCID 0000-0002-1327-2334
Kourosh Saeb ParsyDepartment of Surgery, University of Cambridge, Cambridge, UK.ORCID 0000-0002-0633-3696
Kate H C GowersLungs For Living Research Centre, UCL Respiratory, University College London, London, UK.
Sam M JanesLungs For Living Research Centre, UCL Respiratory, University College London, London, UK.ORCID 0000-0002-6634-5939
Stanley W K NgWellcome Sanger Institute, Hinxton, UK.
Matt HoareEarly Cancer Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5990-9604
Anthony R GreenCambridge Stem Cell Institute, Cambridge, UK.
George S VassiliouWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0003-4337-8022
Ana CvejicWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0003-3204-9311
Markus G ManzDepartment of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-4676-7931
Elisa LaurentiCambridge Stem Cell Institute, Cambridge, UK.ORCID 0000-0002-9917-9092
Iñigo MartincorenaWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0003-1122-4416
Michael R StrattonWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0001-6035-153X
Jyoti NangaliaWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0001-7122-4608
Tim H H CoorensWellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-5826-3554
Peter J CampbellWellcome Sanger Institute, Hinxton, UK. pc8@sanger.ac.uk.ORCID 0000-0002-3921-0510

Funding

Medical Research CouncilWellcome Trust
6 · The paper itself

Abstract

DNA is subject to continual damage, leaving each cell with thousands of individual DNA lesions at any given moment

Indexed as

DNA DamageMutagenesisMutagensMutationBronchiCell CycleFemaleHematopoietic Stem CellsHumansLiverMalePhylogenyTime FactorsMutagens

Identifiers

PMID39814886
PMCPMC11839459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.